調査項目

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst’s Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Table 0A : Global Market for Monoclonal Antibodies in Oncology, Through 2027
Figure 0A : Global Market for Monoclonal Antibodies in Oncology, 2020-2027
Table 0B : Global Market for Monoclonal Antibodies in Oncology, by Type, Through 2027
Figure 0B : Global Market for Monoclonal Antibodies in Oncology, by Type, 2020-2027

Chapter- 3: Market and Technology Background
Monoclonal Antibodies

Chapter- 4: Market Dynamics
Market Drivers
Market Barriers
Opportunities
Impact of COVID-19

Chapter- 5: Market Breakdown by Type
Types of Monoclonal Antibodies for Oncology
Market Overview
Market Revenue
Global Market for Monoclonal Antibodies in Oncology by Type

Chapter- 6: Market Breakdown by Application
Overview
Lung Cancer
Breast Cancer
Colorectal Cancer
Blood Cancer
Other Cancers

Chapter- 7: Market Breakdown by Region
Introduction
North America
Europe
Asia-Pacific
Rest of the World

Chapter- 8: Regulatory Aspects
New Approvals of Monoclonal Antibodies for Oncology
Recalls, Withdrawals, and Safety Alerts

Chapter- 9: Patent Review/ New Developments
New Developments

Chapter- 10: Competitive Landscape
Mergers, Acquisitions, and Collaborations

Chapter- 11: Company Profiles
AMGEN INC.
ASTRAZENECA PHARMACEUTICALS
BRISTOL-MYERS SQUIBB
ELI LILLY
F. HOFFMANN-LA ROCHE AG
GLAXOSMITHKLINE
GILEAD SCIENCES INC.
JOHNSON & JOHNSON
MERCK & CO. INC.
MERCK KGAA
PFIZER INC.
SANOFI S.A.
SEAGEN